Company Profile

Company Overview

At Genomic Expression, we are building a company to address the urgent need for better cancer treatments. Currently only 1 out of 4 cancer treatment prolongs life, yet we spend $100 billion on drugs and 8 million patients die every year from the disease.  Genomic Expression is changing this paradigm by sequencing tumor RNA to find the best drug for the patient, and the best patient for the drug. With four funded programs in various cancer types, including breast and ovarian cancer, Genomic Expression is a first mover in making RNA sequencing actionable in oncology.